Support our Foundation of Myology project
1655 news items
Research
The relevance of genome editing coupled with cell therapy in the treatment of calpainopathies
On 12/05/2023
German researchers have developed a cell therapy coupled with a CRISP-Cas9-based genome editing technique in a transgenic mouse with the c.550delA founder mutation in the…
Research
A reliable biomarker to predict response to gene therapy in SMA
On 12/05/2023
French clinicians from the Filnemus network report the results of a prospective study aimed at measuring the predictive value of muscle action potential amplitude (CMAP)…
Research
Analysis of the largest cohort of patients with anoctaminopathy
On 12/05/2023
An international multicentre study reports the results of the analysis of the characteristics of 234 patients with ANO5-related myopathy (limb-girdle muscular dystrophy type R12 or…
Research
Certain types of dermatomyositis are thought to protect against cancer risk
On 11/05/2023
Dermatomyositis (DM) is generally a disease with an increased risk of developing neoplasia, hence the need for regular monitoring. Researchers from two US centres studied…
Research
An ENMC workshop on dystrophinopathies in women
On 11/05/2023
In May 2022, the European Neuromuscular Center (ENMC) brought together about 20 experts and patient representatives from all over the world to review the pathophysiology,…
Research
Ultrasound useful to assess respiratory effort in MFM patients: a case study
On 11/05/2023
Myofibrillar myopathies (MFMs) are a small but fairly heterogeneous group of neuromuscular diseases characterised, at the histopathological level, by the accumulation of protein products which…
Research
Towards a methodological flexibility of clinical trials in DMD?
On 10/05/2023
An international consortium of researchers and clinicians involved in therapeutic trials in Duchenne muscular dystrophy (DMD) is calling for a methodological revision based on the…
Research
Two major breakthroughs in autoimmune necrotizing myositis
On 09/05/2023
Autoimmune necrotizing myositis (AINM) is a recently described entity related to the deleterious effect of autoantibodies directed against an enzyme, HMG CoA reductase, most often…
Research
A review of the literature profiles scleromyositis as a disease in itself rather than a simple overlap between myositis and scleroderma
On 09/05/2023
A French-Canadian team analysed some sixty publications in order to better define the diagnostic criteria for scleromyositis, an emerging entity. Their review highlights in particular…
Research
Reducing diagnostic error in mitochondrial diseases with the COMMI project
On 09/05/2023
The French network of 11 mitochondrial disease diagnostic laboratories MITODIAG has announced the launch of the COMMI project, which aims to : create a cohort…
Research
Reducing diagnostic error in mitochondrial diseases with the COMMI project
On 09/05/2023
The French network of 11 mitochondrial disease diagnostic laboratories MITODIAG has announced the launch of the COMMI project, which aims to : create a cohort…
Research
The challenge of measuring quality of life in DMD
On 09/05/2023
A Swedish physician specialising in health economics has examined the issue of quality of life in Duchenne muscular dystrophy (DMD), a component that is becoming…
Research
Not all immune checkpoint inhibitor-induced myositis are alike
On 09/05/2023
Spanish and American researchers studied the clinical and serological data of patients with autoimmune myositis in relation to immune checkpoint inhibitor (ICI) treatment. Transcriptomic analysis…
Research
Cardiac involvement is possible in autoimmune necrotizing myopathies
On 05/05/2023
Chinese researchers studied all their cases of autoimmune necrotizing myopathy (AINM) over the period 2011-2022 with a focus on possible cardiac complications: Fifty-seven patients…
Research
Using patient fibroblasts to understand inclusion body myositis
On 05/05/2023
A Spanish team compared the fibroblasts of 14 patients with inclusion body myositis (IBM) to 12 healthy controls. The IBM fibroblasts were found to have:…
Research
Intravenous cyclophosphamide is more effective than other immunosuppressive drugs in interstitial lung disease associated with myositis
On 05/05/2023
A comparison of the efficacy of cyclophosphamide as first-line therapy versus other immunosuppressive therapies (azathioprine, glucocorticoids, mycophenolate mofetil, calcineurin inhibitors, rituximab) was performed in 47…
Research
Two unusual phenotypes reported in inclusion body myositis
On 04/05/2023
Inclusion body myositis (IBM) is an autoimmune myopathy characterised mainly by damage to the flexor digitorum and quadriceps muscles occurring after the age of fifty.…
Research
Phase 2 trial concludes in favour of subcutaneous administration of immunoglobulins in myasthenia gravis
On 04/05/2023
The background treatment of myasthenia gravis (MG) requires, in some cases, the administration of polyvalent immunoglobulins. US clinicians report the results of a multicentre phase…
Research
Genetic analysis strategy in hereditary neuropathies
On 04/05/2023
French clinicians, aiming to guide the genetic diagnosis of patients with hereditary peripheral neuropathy, have outlined in a review the clinical and neurophysiological aspects as…
Research
Publication of results from the IONIS-DMPKRx trial in DM1
On 03/05/2023
IONIS-DMPKRx, also known as baliforsen is an antisense oligonucleotide developed by IONIS Pharmaceuticals in DM1. It was tested in a Phase I/II clinical trial in…